RBC Capital Sees Long-Term Growth Intact at UnitedHealth (UNH) Despite CMS Uncertainty

Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) is recognized as one of the 14 High Yield Dividend Stocks with Sustainable Payouts [1] - RBC Capital has reduced its price target for UnitedHealth from $408 to $361 while maintaining an Outperform rating, citing a long-term adjusted EPS growth target of 13%–16% [2] - The stock experienced a significant decline of nearly 17% from January 26 to January 29, primarily due to a proposal from the Centers for Medicare & Medicaid Services (CMS) to increase 2027 Medicare Advantage rates by only 0.09%, which was much lower than the anticipated 4% to 6% [3][4] Group 2 - UnitedHealth's 2026 revenue guidance fell short of Wall Street expectations, contributing to the stock's decline [3] - The CMS announcement has negatively impacted the health insurance sector, with UnitedHealth being particularly vulnerable due to its status as the largest Medicare insurer in the US by membership [4] - UnitedHealth operates multiple business lines, including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which encompasses Employer & Individual, Medicare & Retirement, and Community & State coverage [5]